GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...
President Ed Seidel has appointed Tami Benham-Deal as acting provost until an interim provost is installed. As acting provost, Benham-Deal will oversee the day-to-day operations of the Office of ...